DSHS Support Documents for CDC Funding Announcement PS 17-1704
The DSHS HIV/STD/TB/Viral Hepatitis Unit has published the following support documents for potential applicants to the recently released Centers for Disease Control and Prevention (CDC) Funding Opportunity Announcement (FOA) PS 17-1704: Comprehensive High-Impact HIV Prevention Projects for Young Men of Color Who Have Sex with Men (YMSM) and Young Transgender (YTG) Persons of Color
The documents include an orientation to the state rules, policies, procedures and requirements potential applicants must follow. We have also posted information on HIV epidemiology and the continuum of care for the populations that need to be targeted.
Processes for obtaining required Attachments B (Health Department Targeted HIV Testing/Partner Services Letter of Agreement) and F (Health Department Letter of Support) to include in your CDC application are below. All potential applicants must attest to their understanding of the Texas rules, policies and procedures and requirements included in the support documents.
- Please contact
Dolores Alvarez, Manager HIV/STD Prevention Services Group to schedule a conference call to review required
Attachment B (PDF : 192 kb) and
Attachment F (PDF : 139 kb). All conference calls must be held by August 31, 2016.
- Prior to the scheduled phone call, each applicant’s leadership and project management must have previously reviewed and attested compliance with state laws, rules, regulations pertaining to HIV testing and Partner Services and issues outlined in Attachment B.
- TWO days prior to the scheduled phone call, the applicant must send a summary or an abstract of the applicant’s proposal, detailing intent to apply for either CATEGORY A or CATEGORY B and listing the proposed service areas to
CDC will hold a pre-application technical assistance conference call on August 25 at 1:00 p.m. CST to provide potential applicants the opportunity to ask CDC representatives questions specific to the FOA. Registration is not required to participate on this call. Dial-in number: 1-855-348-8390 - Conference ID: 72600161.
Additionally, CDC will host three last chance technical assistance conference calls for potential applicants to ask any final questions related to the FOA technical requirements and application submission process. Registration is not required to participate on these calls. Dial-in number: 1-855-348-8390 - Conference ID: 72600161
- August 30 at 12:30 p.m. CST
- September 1 at 10:30 a.m. CST
- September 7 at 1:30 p.m. CST
CDC’s directly funded Capacity Building Assistance providers will be hosting a webinar for potential applicants on HIV Navigation Services. The webinar will be held on August 30 at 1:30 p.m. CST. Please visit the
PS17-1704 website for additional information and to register for the webinar.
CDC is also hosting a CBOFOA email mailbox (
CBOFOA@cdc.gov) and telephone line (404-639-6030). Both will take questions through August 31. All questions received on or before the August 31 deadline will receive a response.
We look forward to working with you on this initiative, and thank you for your continued provision of high-quality HIV prevention services for all Texans. Updated 8/23/2016
Guidance for Preventing Sexual Transmission of Zika Virus
CDC has issued
new interim guidance on preventing sexual transmission of Zika virus after confirming through laboratory testing, in collaboration with Dallas County Health and Human Services, the first case of Zika virus infection in a non-traveler in the continental United States during this outbreak. DSHS also hosts an information page for
Zika news and data from Texas. Updated 8/23/2016
DSHS Releases 2015 Texas HIV and STD Surveillance Reports
The Texas HIV and STD Surveillance Reports are annual reports generated by the Texas Department of State Health Services, TB/HIV/STD Epidemiology and Surveillance Branch. The 2015 reports describe cases reported to the Texas Department of State Health Services Surveillance Program from January 1 to December 31, 2015, as well as historical data. View the
HIV report (PDF: 3,182 kb) and the
STD report (PDF : 1,976 kb). Updated 7/28/2016
Drug Resistant Gonorrhea on the Rise
Gonorrhea is developing a resistance to the last classes of drugs available in the U.S. that are able to cure infection. Changes to gonorrhea treatment recommendations in recent years reduced resistance but those improvements may be short-lived. DSHS recently released a
Dear Colleague letter (PDF : 8,855 kb) detailing the increase in cephalosporin-resistant gonorrhea since 2013.
The letter is aimed at clinicians that treat STDs outlines the new CDC recommendations for gonorrhea treatment. It also provides links to the
Texas gonorrhea response plan and contact information for experts in the field. Posted 12/30/2015
Epi Profile Shows State of HIV in Texas
The DSHS TB/HIV/STD/Viral Hepatitis Unit released the
2014 Texas HIV Integrated Epidemiologic Profile (Epi Profile), a summary of information on known HIV/AIDS cases in Texas. The Epi Profile was created to assist planners, public health professionals, policy makers and other stakeholders at the local and state level. It is a snapshot of the HIV epidemic in Texas at the end of 2014.
Over 80,000 Texans are known to be living with HIV. This does not include the nearly 18,000 persons who are estimated to be living with HIV and unaware of their infection. The face of HIV in Texas is increasingly young, Black or Hispanic, and male. The vast majority of new infections and diagnoses occur in gay or other men who have sex with men (MSM).
You can read the Epi Profile and other reports from the TB/HIV/STD/Viral Hepatitis Unit on the
Reports page. Posted 12/1/2015
Save the Date! 2016 Texas HIV/STD Conference
Please mark your calendars! DSHS will host the 2016 Texas HIV/STD Conference on October 4-6, 2016 at the Renaissance Hotel in Austin, Texas. Guest room reservations will be available in November 2015 and registration will open in spring 2016. A tentative schedule is posted at the
conference website. Additional information will be announced as it becomes available. Updated 8/11/2015
CDC Releases 2015 STD Treatment Guidelines
The U.S. Centers for Disease Control and Prevention (CDC) published the 2015 Sexually Transmitted Diseases Treatment Guidelines [CDC] last month. These guidelines update the 2010 guidelines and include discussions on:
1) alternative treatment regimens for Neisseria gonorrhoeae;
2) the use of nucleic acid amplification tests for the diagnosis of trichomoniasis;
3) alternative treatment options for genital warts;
4) the role of Mycoplasma genitalium in urethritis/cervicitis and treatment-related implications;
5) updated HPV vaccine recommendations and counseling messages;
6) the management of persons who are transgender;
7) annual testing for hepatitis C in persons with HIV infection;
8) updated recommendations for diagnostic evaluation of urethritis; and
9) retesting to detect repeat infection.
Physicians and other health-care providers can use these guidelines to assist in the prevention and treatment of STDs. In addition to the published guidelines, providers may access the guidelines in the formats listed below.
- Wall Chart [CDC] – This poster-sized chart provides an overview of CDC's 2015 STD Treatment Guidelines. The wall chart is ideal for use in doctor offices, nurse’s stations, and other clinical settings. Limited quantities are now available to order through
CDC-INFO on Demand Publications [CDC].
- Pocket Guide [CDC] – A booklet that includes a summary of CDC’s 2015 STD Treatment Guidelines. The pocket guide is small, and printed at a size that can fit in a lab coat, pocket, or desk drawer. Limited quantities are now available to order through
CDC-INFO on Demand Publications [CDC].
- Apple STD Tx Guide 2015 App [CDC] – This easy-to-use mobile reference features a streamlined interface so that providers can quickly and easily access STD treatment and diagnostic information. The free app is currently available for Apple devices. An Android app is being developed and will be available later this summer.
- Evidence Tables [CDC] – These background documents provide a basis for the STD screening, diagnostic, and treatment recommendations included in the 2015 STD Treatment Guidelines.
All of these resources can be found online at
Additionally, CDC’s Division of STD Prevention and the National Network of STD Clinical Prevention Training Centers (NNPTC) hosted a webinar to provide an overview of the updates in the Guidelines and answer questions. The webinar, slides, and continuing education (CE) information are available on the
DSTDP Webinars Page [CDC]. Posted 7/2/2015
DSHS Releases Recommendation for PrEP
Many of you may have heard of Pre-exposure Prophylaxis, or PrEP, by now. PrEP is a very promising prevention option for people who are at high risk of getting HIV. It’s meant to be used consistently, as a pill taken every day, and to be used with other prevention options such as condoms.
Earlier this year, CDC and the U.S. Public Health Service released new clinical guidelines encouraging health care providers to consider prescribing pre-exposure prophylaxis (PrEP) for patients at substantial risk for HIV. CDC also released a letter detailing key actions that an organization could take to help achieve the full promise of PrEP as well as grantee guidance on PrEP related services that can be supported with HIV Prevention funding.
DSHS HIV/STD Prevention and Care Branch has released a
recommendation to contractors informing them DSHS also recommends that PrEP be considered for people who are HIV-negative and at high risk for HIV and asking that they advocate for clients who need PrEP as well as help break down barriers and create pathways to PrEP.
For questions about the DSHS PrEP position statement, contact
Shelley Lucas, Manager, HIV/STD Prevention and Care Branch. Posted 12/1/2014
DSHS Releases Texas HIV Plan for 2014-15
DSHS has released the
2014-15 Texas HIV Plan (PDF : 998 kb) which presents a framework and strategies to reduce the number of new HIV infections and provide treatment and care for those living with HIV. This new plan is intended to:
- Prioritize actions and coordinate the use of resources across individuals and organizations in communities and groups affected by HIV
- Identify common goals
- Harmonize strategies and evaluation
- Enrich local action rather than direct it
You can view the Texas HIV Plan and read about other HIV planning activities on the
HIV and STD Planning page. Posted 5/1/2014
This site contains HIV or STD messages that may not be deemed appropriate for all audiences. Since HIV and other STDs are spread primarily through sexual practices or by sharing needles, messages and programs may address these topics. If you are not seeking such information or may be offended by such materials, please exit this web site.